A detailed history of Sws Partners transactions in Dexcom Inc stock. As of the latest transaction made, Sws Partners holds 55,560 shares of DXCM stock, worth $3.23 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
55,560
Previous 38,102 45.82%
Holding current value
$3.23 Million
Previous $2.56 Million 25.83%
% of portfolio
0.62%
Previous 0.64%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

BUY
$54.84 - $71.06 $957,396 - $1.24 Million
17,458 Added 45.82%
55,560 $3.23 Million
Q3 2025

Oct 16, 2025

BUY
$66.46 - $89.53 $1.27 Million - $1.71 Million
19,073 Added 100.23%
38,102 $2.56 Million
Q2 2025

Jul 17, 2025

BUY
$59.83 - $87.57 $1.14 Million - $1.67 Million
19,029 New
19,029 $1.66 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Sws Partners Portfolio

Follow Sws Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

News

Stay updated on Sws Partners with notifications on news.